Technology News and Research

RSS

New vaccines to counter biological agents such as anthrax

Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.

1 Nov 2004

More research and innovation on child pain and stress reduction is needed

Relief of pain and stress for children receiving emergency medical treatment is a vital, and readily available, component of care.

1 Nov 2004

New rapid gonorrhea test that does not require collection

Potential antimicrobial resistance in the bacteria that cause gonorrhea can be detected without culturing the organism, thanks to a rapid test developed by researchers at Johns Hopkins.

1 Nov 2004

Patent issued for nanotechnology bone biomaterial

Competitive Technologies announced today that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC).

1 Nov 2004

Brain imaging technology shows how the adult dyslexic brain can change

New findings from researchers at Georgetown University Medical Center in collaboration with Wake Forest University School of Medicine have shown that there is hope for individuals suffering a life-long history of reading problems.

1 Nov 2004

First home-testing device for phenylketonuria (PKU) patients

Home-testing kits have made it easier for diabetics and hypertension patients to track their conditions, but such self-monitoring hasn’t been possible for people with phenylketonuria (PKU).

1 Nov 2004

Grant to develop high speed DNA sequence reader

Sequencing of the human genome is one of the major scientific advances of our time. But with 3 billion base pairs, initial sequencing of the human genome took 11 years and cost $1 billion to complete in 2002. Today, it costs up to $50 million to sequence 3 billion base pairs.

1 Nov 2004

Esophageal capsule is convenient, safe and sensitive for visualization of esophageal disorders

Researchers in a multi-center pivotal trial of M2Aâ Esophageal Capsule Endoscopy (Given Imaging, Yoqneam, Israel) found that this new technology is comparable to upper GI endoscopy for the detection of severe esophageal problems.

1 Nov 2004

Drug-loaded contact lenses to treat eye diseases

When a person suffers from eye ailments today, nine times out of ten, he will be prescribed eye drops to treat his illness or relieve his discomfort.

29 Oct 2004

Scientists have uncovered a significant new link in the chain of immune system events through which estrogen prevents bone loss

Through research in mice, the scientists discovered that an immune signaling molecule called type b transforming growth factor (TGFb) is responsible for a cascade of events that leads estrogen to prevent bone loss.

29 Oct 2004

Micro-array technology is revolutionising current drug development

Gene expression micro-array technology is benefiting all phases of the discovery, development and subsequent use of new cancer therapeutics

29 Oct 2004

Will email consultations improve patient care?

Making email communication part of routine medical practice may have unforseen consequences for the NHS, warns a doctor in a letter to this week's BMJ.

29 Oct 2004

Training of primary care physicians helps increase referrals and cardiac rhythm management device sales

The cardiac rhythm management (CRM) market is poised for phenomenal growth with about 22 million cardiac patients worldwide and more people dying of sudden cardiac arrest than from lung/breast cancer and AIDS combined.

28 Oct 2004

Research speeds development of brain-controlled devices that may allow amputees and paraplegics to use their limbs

New research is speeding the development of brain-controlled devices that may soon allow amputees and paraplegics to use their limbs.

28 Oct 2004

Easy-to-make vaccine tackles a range of illnesses

Australian researchers have created a totally synthetic vaccine that is effective against viruses, harmful bacteria and tumours and could lead to a powerful new arsenal of vaccines for humans and animals.

26 Oct 2004

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.

26 Oct 2004

New radiotherapy regime benefits young women with breast cancer

Women under 35 years of age with breast cancer can have an almost 20% lower risk of their disease recurring if they are treated using a new radiotherapy regime.

26 Oct 2004

Project to refine and fine-tune radiotherapy treatment for cancer

The EU-funded GENEPI project will provide the facility for essential research which will improve and refine radiotherapy for European cancer patients

26 Oct 2004

National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer

The Case Comprehensive Cancer Center, which includes The Cleveland Clinic Taussig Cancer Center and the Ireland Cancer Center at University Hospitals of Cleveland, will sponsor a National Cancer Institute symposium exploring the application of nanotechnology in the diagnosis, treatment and prevention of cancer.

25 Oct 2004

Breakthrough discovery in treating narrowed arteries

A breakthrough discovery by Heart and Stroke Foundation researcher Dr. Michael Kutryk that harnesses the body’s own natural defenses to fight narrowing of the arteries has been recognized as “a glimpse into the future” and “potentially one of the biggest advances in cardiology to date”.

25 Oct 2004